Showing results (161-170 of 322) with videos related to
Sort By:
Pageof 33
Nature Chemical Biology|April 6, 2026
Charged molecular glue discovery enabled by targeted degron displayZhe Zhuang, Woong Sub Byun, Jakub Chrustowicz, et al.Nature Genetics|March 17, 2009
A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasmsOuti Kilpivaara, Semanti Mukherjee, Alison M Schram, et al.Nature Medicine|October 19, 2021
Distinction of lymphoid and myeloid clonal hematopoiesisAbhishek Niroula, Aswin Sekar, Mark A Murakami, et al.Cancer Cell|July 14, 2012
Endothelial CCR2 signaling induced by colon carcinoma cells enables extravasation via the JAK2-Stat5 and p38MAPK pathwayMonika Julia Wolf, Alexandra Hoos, Judith Bauer, et al.Blood Cancer Journal|April 13, 2023
Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1Warren Fiskus, Christopher P Mill, Christine Birdwell, et al.Blood|September 17, 2014
TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patientsRafael Bejar, Allegra Lord, Kristen Stevenson, et al.Nature Medicine|March 19, 2013
Macrophages support pathological erythropoiesis in polycythemia vera and β-thalassemiaPedro Ramos, Carla Casu, Sara Gardenghi, et al.Nature Communications|March 26, 2014
Mutations in epigenetic regulators including SETD2 are gained during relapse in paediatric acute lymphoblastic leukaemiaBrenton G Mar, Lars B Bullinger, Kathleen M McLean, et al.JCO Precision Oncology|October 31, 2019
Genomic Biomarkers to Predict Resistance to Hypomethylating Agents in Patients With Myelodysplastic Syndromes Using Artificial IntelligenceAziz Nazha, Mikkael A Sekeres, Rafael Bejar, et al.Blood|January 18, 2023
A practical approach to curate clonal hematopoiesis of indeterminate potential in human genetic data setsCaitlyn Vlasschaert, Taralynn Mack, J Brett Heimlich, et al.Pageof 33